Delivery Order SPE2DB22D1106-SPE2DB24FETP3
- Not listed
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The $3,269.99 firm-fixed-price delivery order is for the supply of 4,564,303,553 units of Amox-Clav 875-125 mg tablets, with an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $3,865.19 Firm Fixed Price delivery order (SPE2DB24FM1YS) issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,565,766,152 units of Amox-Clav 875-125 mg tablets, with a completion date of September 12, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 4,564,368,158 units of Amox-Clav 250-125 mg tablets in 30-count packages. The $11,843.52 firm fixed price delivery order was placed by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,331.78 firm fixed price delivery order is for the supply of Amoxicillin-Clavulanate 1,000-62.5 mg tablets. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This federal contract award is a delivery order for AMOX-CLAV 500-125 MG TABLET 20S issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,167.95 firm fixed-price contract has a completion date of May 19, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,581.72, is for the delivery of AMOX-CLAV 875-125 MG TABLET 20S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 11, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,258.54, is for the delivery of Amoxicillin-Clavulanate 400-57 mg/5 ml suspension in 100 ml bottles. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, valued at $1,182.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of pharmaceutical products, including prescription medications, over-the-counter drugs, and medical supplies. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- This federal contract award, worth $1,752.12, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
- This federal contract award, valued at $1,296.58, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the provision of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and critical care materials such as syringes and test kits. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FETP3Delivery Order
This federal contract award, valued at $1,230.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564702740, a prescription pharmaceutical product, AMOX-CLAV ER 1,000-62.5 MG TAB, with a performance period through May 24, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical and medical supplies to DLA facilities worldwide. This current award is likely a specific order placed against that IDC. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/23/24 |